drugset / Trial / NCT06822153
Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart
RandomizedParallel-groupOpen-labelTreatment
Summary
A single intravenous injection of 0.8mg/kg or 2.8mg/kg Et-26-hcl was given to 18 subjects. The effect of plasma concentration on QT interval was evaluated by C-QTc effect model, and the pharmacokinetic characteristics and safety of ET-26 and etomidate acid were evaluated.
Timeline
- Start
- 2023-11-09
- Primary completion
- 2023-11-21
- Completion
- 2023-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methoxyethyl Etomidate Hydrochloride | Unknown | 0.8 mg/kg | Intravenous |
| Subject | Methoxyethyl Etomidate Hydrochloride | Unknown | 2.8 mg/kg | Intravenous |